- Home
- FNB vs PCVX Comparison
FNB vs PCVX Comparison
Compare FNB & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FNB | PCVX |
|---|---|---|
| Founded | 1864 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 6.1B |
| IPO Year | 2001 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FNB | PCVX |
|---|---|---|
| Price | $16.36 | $58.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $19.10 | ★ $98.33 |
| AVG Volume (30 Days) | ★ 7.0M | 1.1M |
| Earning Date | 04-22-2026 | 05-27-2026 |
| Dividend Yield | ★ 2.93% | N/A |
| EPS Growth | ★ 22.83 | N/A |
| EPS | ★ 1.56 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.53 | N/A |
| Revenue Next Year | $7.90 | N/A |
| P/E Ratio | $10.53 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.93 | $28.09 |
| 52 Week High | $19.14 | $76.61 |
Technical Indicators
Market Signals| Indicator | FNB | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 33.56 | 52.93 |
| Support Level | $15.47 | $42.30 |
| Resistance Level | $16.50 | $65.00 |
| Average True Range (ATR) | 0.54 | 3.08 |
| MACD | -0.18 | -0.53 |
| Stochastic Oscillator | 20.32 | 35.38 |
Price Performance
Historical ComparisonAbout FNB F.N.B. Corporation
F N B Corp provides a full range of financial services, principally to consumers, corporations, governments and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management and Insurance. The majority of revenue is from the Community banking segment. It offers commercial & consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets & lease financing. Consumer banking products & services include deposit products, mortgage lending, & consumer lending & a complete suite of mobile & online banking services.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.